Viewing Study NCT06554535


Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2025-12-28 @ 12:30 AM
Study NCT ID: NCT06554535
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-15
First Post: 2024-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module